Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer level metastasized prostate psa |
|
Prostate Cancer Case Studies - ProstateLine.com The median survival for men with metastatic prostate cancer is about 30 months In 1995 his prostate-specific antigen (PSA) level was 11 eg/l and in 1999 ACS :: Can Prostate Cancer Be Found Early? When prostate cancer develops, the PSA level usually goes above 4. . outside of the prostate (metastatic disease), the actual PSA number is probably not The Natural History Of Noncastrate Metastatic Prostate Cancer Median PSA level at initial noncastrate metastasis was 13.5ng/ml and the median These data suggest that the risk of dying form prostate cancer is best Prostate cancer: Does PSA level affect prognosis? - MayoClinic.com At the time of your initial diagnosis of prostate cancer, your PSA level helps determine how likely it is that your cancer has spread (metastasized). PSA Predicts Prostate Cancer Survival After seven months of androgen-deprivation therapy, which is standard treatment for metastatic prostate cancer, men with low PSA levels have only one-fourth Prostate Cancer (Metastasized/Late Stage) - Disease Therapies Protocol PROSTATE CANCER (METASTASIZED/LATE STAGE). Stephen B. Strum, M.D., F.A.C.P. In addition, the use of routine free/total PSA levels should increase our Prostate specific antigen - Wikipedia, the free encyclopedia Men with prostate cancer whose PSA level increased by more than 2.0 ng per in order to determine the origin of maligant cells that have metastasized. Prostate Cancer - All About Prostate Cancer The men, all with PSA levels <100 ng/mL and no evidence of metastasis were of men with metastasized prostate cancer had alerting levels of EPCA-2. PSA Predicts Treatment Success In Advanced Prostate Cancer A man's prostate specific antigen, or PSA, level after seven months of hormone about using PSA to predict survival in metastatic prostate cancer is that Metastatic prostate cancer with a normal prostate-specific antigen In the screening for prostate cancer, the possibility of. false negatives, with PSA levels of < 4 ng/ml and with. normal rectal examination, is around 10% Metastatic prostate cancer with normal level of serum prostate In advanced prostate cancer patients with low PSA level,. those markers may aid in the follow up of disease. Key words: Low PSA, Metastasis, Prostate cancer |
| cancer level metastasized prostate psa |
|
cancer curing prostate back pain prostate cancer cancer diagnosis more prostate test cryosurgery for prostate surgery |